111 (YI) Cash & Equivalents Growth (3y) (2020 - 2025)
111 (YI) Cash & Equivalents Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 160.31% |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -5.28% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 12.24% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -0.44% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.08% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 71.45% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -8.72% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -65.03% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.72% |
| Sep 30, 2025 | -13.70% |
| Jun 30, 2025 | -11.01% |
| Mar 31, 2025 | -17.29% |
| Dec 31, 2024 | -14.63% |
| Sep 30, 2024 | -11.20% |
| Jun 30, 2024 | -24.29% |
| Mar 31, 2024 | -16.98% |
| Dec 31, 2023 | -22.42% |
| Sep 30, 2023 | -13.79% |
| Jun 30, 2023 | -5.33% |
| Mar 31, 2023 | 6.74% |
| Dec 31, 2022 | 4.72% |
| Sep 30, 2022 | 7.84% |
| Jun 30, 2022 | 0.95% |
| Mar 31, 2022 | 3.66% |
| Dec 31, 2021 | -5.73% |
| Sep 30, 2021 | -5.47% |
| Jun 30, 2021 | 28.77% |
| Mar 31, 2021 | 112.89% |